James M. Gower
2012
In 2012, James M. Gower earned a total compensation of $2.3M as Former Chief Executive Officer, Chairman of the Board and Director at Rigel Pharmaceuticals, a 59% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $382,819 |
|---|---|
| Option Awards | $1,240,695 |
| Salary | $671,612 |
| Other | $5,148 |
| Total | $2,300,274 |
Gower received $1.2M in option awards, accounting for 54% of the total pay in 2012.
Gower also received $382.8K in non-equity incentive plan, $671.6K in salary and $5.1K in other compensation.
Rankings
In 2012, James M. Gower's compensation ranked 3,090th out of 11,487 executives tracked by ExecPay. In other words, Gower earned more than 73.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,090 out of 11,487 | 73rd |
Division Manufacturing | 1,078 out of 4,253 | 75th |
Major group Chemicals And Allied Products | 242 out of 1,203 | 80th |
Industry group Drugs | 142 out of 925 | 85th |
Industry Pharmaceutical Preparations | 115 out of 700 | 84th |
Source: SEC filing on March 30, 2015.
Gower's colleagues
We found four more compensation records of executives who worked with James M. Gower at Rigel Pharmaceuticals in 2012.
2012
Donald Payan
Rigel Pharmaceuticals
Executive Vice President, President of Discovery and Research
2012
Raul Rodriguez
Rigel Pharmaceuticals
Chief Executive Officer
2012
Elliott Grossbard
Rigel Pharmaceuticals
Chief Medical Officer
2012
Ryan Maynard
Rigel Pharmaceuticals